This study aimed to assess the association between biological tumor burden in pre-and post-operative status and overall survival (OS) in isocitrate dehydrogenase (IDH) wild-type gliomas, and to evaluate which volume was the best predictor of OS. Thirty-four patients with treatment-naïve IDH wild-type gliomas (grade II, 6; III, 15; IV, 13) were retrospectively included. Three pre-operative tumor regions of interest (ROIs) were segmented based on the contrast-enhanced (CE), uid-attenuated inversion recovery (FLAIR) hyperintense, and 3,4-dihydroxy-6-[ 18 F]-uoro-L-phenylalanine (FDOPA) hypermetabolic regions. Resected ROIs were segmented from the post-operative images. Residual CE, FLAIR hyperintense, and FDOPA hypermetabolic ROIs were created by subtracting resected ROIs from pre-operative ROIs. Cox regression was conducted to investigate the association of OS with the volume of each ROI. Residual CE volume had a signi cant association with OS (hazard ratio [HR] = 1.26, P = 0.039), but this effect disappeared when controlling for tumor grade. Residual FDOPA hypermetabolic volume was signi cantly associated with OS (HR = 1.18, P = 0.008), even when controlling for tumor grade. FLAIR hyperintense volume showed no signi cant association with OS. Residual FDOPA hypermetabolic burden predicted OS for IDH wild-type gliomas, regardless of tumor grade. Furthermore, removing hypermetabolic and CE regions may improve the prognosis.